Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New serine/threonine-protein kinase ATR inhibitors claimed

Dec. 15, 2011

ArQule and Daiichi Sankyo disclose preclinical findings on ARQ-092

Dec. 15, 2011

MicroRNA therapeutics discovery effort begins in glioblastoma multiforme

Dec. 14, 2011

Eisai reports new agents with antitumor potential

Dec. 14, 2011

New inhibitors of cytokine signaling designed in U.S.

Dec. 14, 2011

Geron begins phase II study of GRN-1005

Dec. 14, 2011

Chinese organizations patent new anticancer agents

Dec. 14, 2011

CSF-1-R-targeted antibody shows promise in proof-of-principle study

Dec. 14, 2011

First data reported on Graspa in older patients with Ph- ALL

Dec. 14, 2011

FDA grants standard review status for carfilzomib NDA

Dec. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...